 | Lexicon Pharmaceuticals, Inc. | |||
| NMS : LXRX || Location: United States | ||||
$1.66+0.03 (+1.84%) |
1.81 M | 1.61 - 1.69 | ||
| Last Updated:America/New_York | Volume | Day range |
Total Call Open Interest - | Total Put Open Interest -
Today's Total Call volume - | Total Put volume -
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 21.913 M |
| March 15, 2024 | 21.346 M |
| Feb. 29, 2024 | 21.065 M |
| Feb. 15, 2024 | 23.411 M |
| Jan. 31, 2024 | 23.033 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.22 | -0.20 | 9.75% |
| 09/30/2023 | -0.22 | -0.21 | 4.11% |
| 06/30/2023 | -0.18 | -0.22 | -23.46% |
| 03/31/2023 | -0.18 | -0.17 | 7.00% |
| 12/31/2022 | -0.14 | -0.16 | -17.04% |
LXRX Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 246.237M | Shares Float | 100.029M |
| Short Float | 21.913M | Market Cap | 401.37M |
| Institution ownership | 82.16% | Insider ownership | 1.665% |
| Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.80 | Forward EPS | -0.66 |